28 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

D3.260 - Bempedoic acid allergy in a patient with hypercholesterolemia

Thumbnail

- D3.262 - Bempedoic acid allergy in a statin-intolerant patient with hypercholesterolemia

Thumbnail

D3.252 - Azithromycin and Mycoplasma pneumonia: an unusual Stevens-Johnson syndrome case

Thumbnail

D3.256 - Is an Early-Type Hypersensitivity Reaction Possible with Both Peroral and Parenteral Anticoagulant Drugs? A Successful 2-Day Peroral Desensitization Protocol to Rivaroxaban

Thumbnail

D3.257 - Two cases of propofol anaphylaxis revealed by provocation test

Thumbnail

D3.258 - Probable drug- induced Enterocolitis Syndrome (DIES) caused by Amoxicillin

Thumbnail

D3.259 - KOLLIPHOR : An excipient to be futher explored

Thumbnail

D3.263 - Rare case of anaphylaxis to lidocaine in skin testing during perioperative anaphylaxis investigation

Thumbnail

D3.264 - Pioneering study evaluating the Basophil Activation Test (BAT), PENFAST and skin sensitization to penicillin in patients with gestational syphilis

Thumbnail

D3.333 - Unveiling the Role of PGD2/CRTH2 Signaling in Antigen-Specific IgE Production